Ursodeoxycholic Acid (UDCA) in Preventing Hepatobiliary and Colorectal Malignancy in Surveillance Patients with Primary Sclerosing Cholangitis (PSC)
Ontology highlight
ABSTRACT: Primary objectives: (i) To assess in incidence of biliary malignancy as assessed by surveillance MR/MRCP in patients with PSC with and without response to UDCA(ii) To assess in incidence of colorectal malignancy as assessed by surveillance colonoscopy in patients with PSC with and without response to UDCA
Primary endpoints: - any hepatobiliary malignancy including low-grade dysplasia detected by surveillance MRCP- any colorectal malignancy including low-grade dysplasia detected by surveillance colonoscopy
DISEASE(S): Primary Sclerosing Cholangitis With Or Without Concomitant Inflammatory Bowel Disease Included In An Unlimited Surveillance Program For Hepatobiliary And Colorectal Malignancy
PROVIDER: 2534809 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA